McKesson Corporation (MCK) To Go Ex-Dividend on March 2nd

McKesson Corporation (NYSE:MCK) announced a quarterly dividend on Wednesday, January 28th. Shareholders of record on Monday, March 2nd will be paid a dividend of 0.82 per share on Wednesday, April 1st. This represents a c) dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, March 2nd.

McKesson has increased its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 17 years. McKesson has a payout ratio of 7.8% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect McKesson to earn $36.64 per share next year, which means the company should continue to be able to cover its $3.28 annual dividend with an expected future payout ratio of 9.0%.

McKesson Stock Down 0.7%

NYSE MCK opened at $820.85 on Friday. The stock’s 50-day moving average price is $828.79 and its 200-day moving average price is $772.77. The company has a market capitalization of $101.32 billion, a P/E ratio of 25.55, a price-to-earnings-growth ratio of 1.36 and a beta of 0.41. McKesson has a 52 week low of $570.51 and a 52 week high of $895.58.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $8.84 by $1.02. McKesson had a net margin of 1.04% and a negative return on equity of 248.14%. The company had revenue of $103.15 billion during the quarter, compared to analyst estimates of $103.80 billion. During the same period in the prior year, the firm posted $7.07 EPS. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. Research analysts anticipate that McKesson will post 32.77 EPS for the current year.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.